![Fredrik Dahl](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fredrik Dahl
Directeur/Membre du Conseil chez
DEVYSER DIAGNOSTICS AB
Fortune : 444 692 $ au 31/05/2026
Profil
Fredrik Dahl is the founder of Colibri Ventures AB,Pixelgen Technologies AB. Currently, Dr. Dahl is Chairman at Faboss Invest AB, Director at Devyser Diagnostics AB starting 2025, Director at Nucleus Capital AB, and Director at Llya Pharma AB. Formerly, Dr. Dahl was Director at Moligo Technologies AB, Chief Technology Officer at Halo Genomics AB, and Chief Technology Officer at Vanadis Diagnostics AB. Education includes undergraduate and doctorate degrees from the University of Uppsala.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 07/05/2025 | 44 150 ( 0,27% ) | 444 692 $ | 31/05/2026 |
Postes actifs de Fredrik Dahl
| Sociétés | Poste | Début |
|---|---|---|
| DEVYSER DIAGNOSTICS AB | Directeur/Membre du Conseil | 01/01/2021 |
Colibri Ventures AB | Fondateur | - |
Faboss Invest AB | Président | - |
Nucleus Capital AB | Directeur/Membre du Conseil | - |
Pixelgen Technologies AB
 Pixelgen Technologies AB Packaged SoftwareTechnology Services Develops bio-analytical tools for immune cell surface protein | Fondateur | - |
Llya Pharma AB | Directeur/Membre du Conseil | - |
Anciens postes connus de Fredrik Dahl
| Sociétés | Poste | Fin |
|---|---|---|
Vanadis Diagnostics AB
 Vanadis Diagnostics AB Miscellaneous Commercial ServicesCommercial Services Develops novel solution for non-invasive prenatal testing | Directeur Technique/Scientifique/R&D | - |
Halo Genomics AB
 Halo Genomics AB Medical/Nursing ServicesHealth Services Develops products for preparation of DNA for the next generation sequencing platforms | Directeur Technique/Scientifique/R&D | - |
Moligo Technologies AB
 Moligo Technologies AB BiotechnologyHealth Technology Engages in producing ultrapure DNA | Directeur/Membre du Conseil | - |
Formation de Fredrik Dahl
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
University of Uppsala
 University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Halo Genomics AB
Halo Genomics AB Medical/Nursing ServicesHealth Services Develops products for preparation of DNA for the next generation sequencing platforms | Health Services |
Devyser Diagnostics AB
 Devyser Diagnostics AB Medical SpecialtiesHealth Technology Manufactures and sells diagnostic kits | Health Technology |
Vanadis Diagnostics AB
Vanadis Diagnostics AB Miscellaneous Commercial ServicesCommercial Services Develops novel solution for non-invasive prenatal testing | Commercial Services |
Colibri Ventures AB | |
Faboss Invest AB | |
Moligo Technologies AB
Moligo Technologies AB BiotechnologyHealth Technology Engages in producing ultrapure DNA | Health Technology |
Pixelgen Technologies AB
Pixelgen Technologies AB Packaged SoftwareTechnology Services Develops bio-analytical tools for immune cell surface protein | Technology Services |
Nucleus Capital AB | |
Llya Pharma AB |
